Surgical Innovations Group
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.14-3.8728.9636.9232.03-6.18-4.20-48.2656.53-10.99-8.63-6.18
Price/Sales ratio
2.671.443.402.642.111.502.172.411.310.461.421.50
Price/Book Value ratio
1.762.003.551.681.611.321.242.061.360.531.441.32
Price/Cash Flow ratio
-22.235.237.2814.3714.0727.2513.21-50.8230.7013.9917.9514.07
Price/Free Cash Flow ratio
-5.177.449.2427.7419.95207.5815.52-20.19-25.21-19.4344.0619.95
Price/Earnings Growth ratio
0.000.04-0.21-0.792.560.01-0.230.55-0.350.04-0.090.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
29.43%13.97%33.83%42.49%42.59%40.37%20.09%34.30%34.58%26.37%40.93%40.93%
Operating Profit Margin
-242.81%-36.11%7.70%6.63%5.65%-22.67%-59.89%-5.25%0.36%-5.11%0.78%0.78%
Pretax Profit Margin
-243.95%-38.86%4.56%6.19%4.69%-24.18%-52.25%-6.41%-0.50%-6.05%-16.84%-24.18%
Net Profit Margin
-234.72%-37.18%11.75%7.15%6.60%-24.40%-51.76%-4.99%2.32%-4.23%-16.52%-24.40%
Effective Tax Rate
3.78%4.32%-157.55%-15.49%-40.77%-0.88%0.93%22.05%563.15%30.08%1.93%-40.77%
Return on Assets
-83.88%-26.16%10.47%3.37%3.85%-16.05%-20.04%-2.90%1.69%-3.55%-11.27%-16.05%
Return On Equity
-154.55%-51.73%12.26%4.56%5.02%-21.48%-29.54%-4.27%2.40%-4.85%-16.41%-21.48%
Return on Capital Employed
-99.36%-28.31%8.02%3.62%3.75%-17.39%-26.99%-4.14%0.32%-5.25%0.67%0.67%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A3.79N/AN/AN/A2.57N/A
Quick Ratio
1.553.342.181.462.371.642.851.281.451.230.961.64
Cash ratio
0.471.220.780.671.070.552.290.880.750.460.960.96
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
552.44148.66135.52178.91120.73166.81156.40180.52155.58117.77174.07120.73
Operating Cycle
552.44148.66135.52178.91120.73166.81156.40180.52155.58117.77174.07120.73
Days of Payables Outstanding
100.0131.6521.4776.7262.7758.5154.0666.3669.8748.2481.7162.77
Cash Conversion Cycle
452.43117.01114.05102.1857.96108.30102.34114.1585.7169.53-38.78108.30
Debt Ratios
Debt Ratio
0.300.38N/A0.130.110.040.130.110.070.050.320.11
Debt Equity Ratio
0.560.75N/A0.170.140.060.190.170.110.080.480.14
Long-term Debt to Capitalization
0.360.43N/A0.130.110.040.14N/A0.060.040.140.11
Total Debt to Capitalization
0.360.43N/A0.150.120.060.160.140.090.070.180.12
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-27.47N/AN/AN/A0.57N/A
Cash Flow to Debt Ratio
-0.130.50N/A0.660.780.730.47-0.230.400.460.360.73
Company Equity Multiplier
1.841.971.171.351.301.331.471.471.421.361.481.30
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.120.270.460.180.150.050.16-0.040.040.030.070.07
Free Cash Flow / Operating Cash Flow Ratio
4.300.700.780.510.700.130.852.51-1.21-0.720.400.13
Cash Flow Coverage Ratio
-0.130.50N/A0.660.780.730.47-0.230.400.460.360.73
Short Term Coverage Ratio
N/AN/AN/A5.365.7423.49-0.231.271.131.532
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A